Rani gets financial backing to the tune of US$69m as it looks to bring injectable biologics the oral route

Rani Therapeutics, a clinical-stage biopharma company and developer of the RaniPill robotic pill, today announced that it has raised US$69m in a Series E financing round, bringing total funding to date to US$211.